Press Сentre
Наши новости
On June 10–17, 2019, a delegation of leading cardiac surgeons from China officially visited Russia at CardioSystemPharma’s invitation for scientific exchange and establishment of the Russian–Chinese international expert research center for cardiac surgery. The delegation included representatives of the Beijing Cardiac Surgery Center Fuwai, the ...
13.09.2019
On June 29, Vladimir Zelman, the prominent Soviet and American neuroanesthesiologist and head of the Anesthesiology and Intensive Care Department at the clinic of the University of Southern California, visited ChemRar High Tech Center. Professor Zelman is one of the best doctors in the United States and one of the most active supporters of the ...
13.09.2019
CardioSystemPharma company, a subsidiary of ChemRar Group, has introduced a unique Russian innovative cardioplegic drug Normacor® to the leading Chinese cardiosurgeons on the 5th International Forum One Belt One Road: Pudong, which took place on May 16 at Shanghai International Conference Center, China.
Normacor® is intended for advanced cardiac ...
13.09.2019
In June 28–30, Viriom Company of High-Tech ChemRar Centre, a resident of biomedicine technologies cluster of Skolkovo Foundation, presented the results of pre-clinical studies of VM-1500A-LAI drug at the International Asian-Pacific Conference on HIV infection in Hong Kong (APACC 2018).
This is a long-acting injection formulation of active ...
09.07.2018
BioInegrator, the company of the ChemRar Group, participated in the School on Demielinising and Neurodegenerative Diseases Scientific and Practical Conference, having become one of its sponsors. The event was held on May 25–26 in Krasnoyarsk.
Infectious complications of the second-line DMT, in particular, the Progressive Multifocal ...
28.06.2018
On June 20–22, 2018, ChemRar Group participated in international exhibition of pharmaceutical technologies, ingredients and products CPhI China in Shanghai as part of the united Russian exposition supported by Russian Ministry of Industry and Trade. The business mission of Russian pharmaceutical developers and manufacturers aimed to increase the ...
26.06.2018
On May 30th, the ceremonial rewarding of winners and prizers of 17th Scientific and Practical Conference “Start into innovations” who received grants from the Physical-engineering Lyceum’s development foundation was held in Pyotr Kapitsa Physical-engineering Lyceum.
Many projects were carried out under scientific guidance of scientists from ...
05.06.2018
IPHARMA of ChemRar Group participated in 10th DIA China Annual Meeting, which was held on May 23–25, 2018, and gathered more than 2,000 professionals from various countries and fields of pharmaceutical R&D industry to discuss changes in innovation segment and regulatory system of Chinese healthcare.
PRC’s pharmaceutical market is top second ...
01.06.2018
In 2016–17 BioIntegrator conducted a big surveillance program to approve safety profile of domestic drug Nescler (INN Fingolimod) for Russian patients suffering remitting multiple sclerosis.
The program confirmed a favorable safety profile of Nescler that was comparable to the original product, Gilenia.
Results of the ...
16.05.2018
On April 18, 2018, an extended board meeting of Russian Ministry of Industry and Trade was held featuring Deputy Prime Ministers of Russian Government – Dmitry Rogozin, Arkady Dvorkovich, Olga Golodets, as well as other members of the Russian Government. At this meeting, Denis Manturov, Minister of Industry and Trade, reported on the Ministry’s ...
23.04.2018
During April and May 2018, experts and leaders of the ChemRar Group will conduct a series of workshops on various business topics at the Moscow Institute of Physics and Technology as a part of the Business for Dummies educational course. Although the course was created for the students of Innovative Pharmaceutics, Medical Technology and ...
03.04.2018
ChemRar Group took part in the first pharmaceutical subgroup joint meeting of the Russian-Italian task force on industrial development and high-tech solutions, which was held in Milan on March 19–20, 2018. At the meeting, Russia was presented by a substantial delegation of executives of Russian pharmaceutical enterprises including APS Tecnologies ...
26.03.2018
Публикации в печатных и электронных СМИ
Видео
Фото
